Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Accurate timing remains critical for the math to work correctly
Why indeed would anyone take such a chance
Brain Sciences (2021) This study by an independent research group (outside the original Washington State University team) demonstrated that Dihexa rescues cognitive impairment in an Alzheimer's disease mouse model (APP/PS1 transgenic mice)
Log in Sign up
GHK-Cu and Rosuvastatin Interaction: Safety, Mechanisms, and Clinical Guidance At a glance Direct interaction evidence / none published as of May 2026 GHK-Cu metabolism / peptidase degradation, not CYP-mediated Rosuvastatin metabolism / minimal CYP2C9, primarily OATP1B1/1B3 hepatic uptake Overlapping CYP liability / none identified Copper load concern / low at typical GHK-Cu doses (1-3 mg/day subcutaneous) Rosuvastatin muscle risk / myopathy incidence approximately 0.1% per FDA label Monitoring recommendation / CK at baseline and if symptoms arise
US$ 29.61
US$ 20.70
US$ 28.57
US$ 29.32
US$ 27.13
US$ 23.29
